 |
|
|
|
|
|
|
| The following information (Health Effects, Handling/Disposal, and Ingredients) is taken from the product label and/or the Material Safety Data Sheet (MSDS) prepared by the manufacturer. The National Library of Medicine does not test products nor does it evaluate information from the product label or the MSDS.
|
 |
|
|
|
Health Effects
|
|
Warning:
CAUTION
KEEP OUT OF REACH OF CHILDREN
PRECAUTIONARY STATEMENTS
HAZARDS TO HUMANS AND DOMESTIC ANIMALS: CAUTION � Harmful if
swallowed. Avoid breathing of spray mist. Avoid contact with skin. Wash thoroughly after handling. Do not contaminate food or feed products.
|
From MSDS
May cause serious injury. Inhalation of excessive amounts may cause upper respiratory tract irritation.
Symptoms include headaches, dizziness, incoordination, drowsiness and unconsciousness.
|
From MSDS
Repeated exposure to cholinesterase inhibitors may, without warning, cause increased susceptibility to doses of any other cholinesterase inhibitor. Kidney and liver damage is possible from exposure to xylenes over long periods.
|
From MSDS
CARCINOGENICITY: NE
NTP: NE
IARC MONOGRAPHS: NE
OSHA REGULATED: NE
|
From MSDS
PROCEDURE:
INHALATION: Remove to fresh air. Consult a physician if symptoms or irritation develops.
SKIN: Remove any contaminated clothing. Wash skin with soap and water. Call a physician if irritation persists. Launder clothing before reuse.
INGESTION: Do not induce vomiting. call a physician and/or transport to an emergency facility.
EYES: Irrigate immediately and continuously for 15 minutes. Consult a physician.
MEDICAL CONDITIONS GENERALLY AGGRAVATED BY EXPOSURE: Any disease, medication, or prior exposure which reduces normal cholinesterase activity may increase the susceptibility to the toxic effect of the active ingredient.
NOTE TO PHYSICIAN: Active ingredient is a cholinesterase inhibitor affecting the central and peripheral nervous systems and producing cardiac and respiratory depression. Atropine sulfate in large doses is an antidote. Two to four mg intravenously or intramuscularly as soon as cyanosis is overcome. Repeat at 5 to 10 minutes intervals until signs of atropinization appear. 2-PAM chloride is a pharmacological antidote and may be administered as an adjunct to, but not a substitute for atropine, which is a symptomatic and often
lifesaving antidote.
DO NOT GIVE MORPHINE OR TRANQUILLIZERS. At first sign of pulmonary edema, the patient should be given supplemental oxygen and treated symptomatically. Continued absorption of malathion may occur and relapse may occur after initial improvement.
Very close supervision of the patient is indicated for at least 48 hours.
|
| N |
| N |
| N |
0 = Minimal; 1 = Slight; 2 = Moderate; 3 = Serious; 4 = Severe;
N = No information provided by manufacturer; * = Chronic Health Hazard |
| 2001-08-28 |
|
|
|
|
|
|
|
|
Handling/Disposal
|
From MSDS
Do not take internally. Avoid contact with skin, eyes and clothing. Wash after handling. Do not contaminate water by disposal of equipment washwaters.
STORAGE: Store in a cool, dry place out of reach of children and animals.
From Label:
Storage � Do not contaminate water, food or feed by storage or disposal. Store in original container until used. Do not store, use or spill near heat or open flame. Store out of reach of children and domestic animals.
|
From Label
Disposal � Triple rinse (or equivalent), then offer for recycling or reconditioning, or puncture and dispose of in a sanitary landfill, or by incineration, or if allowed by state and local authorities, by burning. If burned, stay out of smoke. Wastes resulting from the use of this product may be disposed of on site or at an approved waste disposal facility.
|
|
|
|
|
|
|
|
|
Ingredients from MSDS/Label
|
|
|
|
|
|
|
|
|
|
Home
| Brands | Manufacturers
| Ingredients | Health
Effects
|
|
